DRSP-EE

DRUG3 trials

Sponsors

Organon and Co

Conditions

Contraception

Phase 3

Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)

CompletedNCT00413062

Organon and CoContraception

Start: 2006-06-30End: 2008-08-31Updated: 2022-02-09

Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)

CompletedNCT00511433

Organon and CoContraception

Start: 2006-10-31End: 2008-01-31Updated: 2022-02-09

Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724)

CompletedNCT00511199

Organon and CoContraception

Start: 2006-05-01End: 2008-04-01Updated: 2022-02-09

Related Papers

Comparative analysis of the effects of nomegestrol acetate/17 β-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrhea

The European Journal of Contraception & Reproductive Health Care2015-02-2534 citations

Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17β-estradiol: a randomized controlled trial.

2012-05-0139 citations